GNRH1 and endometriosis: In a recent systematic review of 9 randomized controlled trials, Dienogest in a dose of 2 mg/day for periods ranging from 3 to 12 months was more effective than placebo and was comparable to GnRH agonist in controlling endometriosis symptoms [11].